• Latest Posts

LIfT BioSciences gets a double boost

Beyond Biotech podcast 26: CellCentric, MicrofluidX, Potter Clarkson

In Depth 15 Dec 2022

To avoid stagnation, the EU must refine its ATMP regulation

Therabest and Glycotope to assess breast cancer combination treatment

MicrofluidX raises £3.3M to develop advanced therapy manufacturing platform

AstraZeneca splashes out up to $320M on T-cell receptor therapy company


BioPharma Dynamics expands to provide more solutions for cell and gene therapy industry

Replay receives $1.5M grant for hypoimmunogenic technology platform

Growth in UK cell and gene therapy sector continues

In Depth 3 Nov 2022

What’s on the horizon for gene editing-based therapies?

In Depth 20 Oct 2022

Opportunities and challenges for cell and gene therapy investments

Agreement to take advantage of stem cells from first teeth